Valuation: Procter & Gamble Health Limited

Market Cap 91.4B 954M 832M 783M 713M 1.34B 1.34B 9.38B 3.62B 46.56B 3.58B 3.5B 150B P/E 2027 *
24.9x
P/E 2028 * 22.4x
Enterprise Value 91.4B 954M 832M 783M 713M 1.34B 1.34B 9.38B 3.62B 46.56B 3.58B 3.5B 150B EV / Sales 2027 *
5.91x
EV / Sales 2028 * 5.24x
Free-Float
47.81%
Yield 2027 *
1.98%
Yield 2028 * 2.14%
1 day-0.82%
1 week+0.67%
Current month-5.20%
1 month-6.77%
3 months-13.27%
6 months+13.42%
Current year-4.22%
1 week 5,420.45
Extreme 5420.45
5,554.5
1 month 5,324.4
Extreme 5324.4
5,910
Current year 4,699.7
Extreme 4699.7
6,955
1 year 4,699.7
Extreme 4699.7
6,955
3 years 4,640.3
Extreme 4640.3
6,955
5 years 3,883
Extreme 3883
6,955
10 years 681
Extreme 681
7,499.95
Manager TitleAgeSince
Chief Executive Officer 57 2018-03-31
Director of Finance/CFO - 2025-09-30
Chief Tech/Sci/R&D Officer - 2025-08-31
Director TitleAgeSince
Director/Board Member 57 2018-03-31
Director/Board Member 51 2019-05-31
Chairman 69 2025-03-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.82%+0.67%-12.69%+12.34% 954M
-1.20%+0.62%+12.31%+63.06% 46.81B
-1.02%-1.29%+36.59%+104.00% 37.1B
+0.11%+5.76%+12.22%+95.15% 12.09B
-0.14%+2.45%-10.25%+16.71% 11.69B
0.00%-0.95%+19.27%+142.99% 9.03B
-0.93%+0.95%+27.42%+38.91% 7.45B
+0.47%+3.78%+21.98%+206.60% 7.22B
-0.06%+2.20%+39.67%-16.79% 7.13B
+3.26%+3.77%-40.07%+13.57% 5.19B
Average -0.03%+1.96%+10.64%+67.65% 14.47B
Weighted average by Cap. -0.57%+1.03%+17.70%+77.36%

Financials

2027 *2028 *
Net sales 15.47B 162M 141M 133M 121M 226M 227M 1.59B 612M 7.88B 607M 593M 25.44B 17.43B 182M 159M 149M 136M 255M 255M 1.79B 690M 8.88B 684M 668M 28.66B
Net income 3.67B 38.32M 33.41M 31.47M 28.66M 53.74M 53.8M 377M 145M 1.87B 144M 141M 6.04B 4.09B 42.66M 37.2M 35.03M 31.9M 59.82M 59.89M 420M 162M 2.08B 160M 157M 6.72B
Net Debt - -
Logo Procter & Gamble Health Limited
Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.
Employees
1,276
Date Price Change Volume
26-09-22 5,460.75 -0.82% 291
26-09-21 ₹5,506.15 +0.08% 415
26-09-18 ₹5,502.00 +1.23% 252
26-09-17 ₹5,434.95 -0.45% 130
26-09-16 ₹5,459.65 +0.65% 273
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PGHL Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!